
FTC Intensifies Oversight of Pharma Industry as Patent Expirations Approach for Blockbuster Drugs
The U.S. Federal Trade Commission is increasing its scrutiny of the pharmaceutical industry as several top selling drugs approach the end of their patent protections,












